Strong results from Swiss group boost food stocks, offsetting losses elsewhere

Company will pay over money within seven days of formal agreement being signed

Tax dispute dates back to a 2016 audit by Revenue

Ratings agency turns negative on outlook for ‘over-the-counter’ medicines group over potential debt burden

ECB pledges to keep interest rates at record lows for even longer

Business interview: CEO Murray Kessler talks Covid and sorting out Perrigo’s Irish tax bill

Revenue Commissioners and Perrigo have been in intense discussions for months

Fallout from controversial approval of Alzheimer’s drug is a concern

A decision by the US FDA to approve aducanumab has alarmed many experts

Bank shares suffer as bond yields tighten

Market edgy ahead of ECB policy decision and US inflation data

Medical community sharply divided on the benefits of this drug in treating dementia

Price over double the highest industry analyst estimate triggers renewed criticism

Many scientists opposed approval of controversial treatment, saying it did not work

Consumer healthcare group hit with largest tax assessment ever issued by commissioners

Amount is second-largest in the history of the State, behind only high-profile Apple case

Irish-founded firm is listed on Toronto Stock Exchange but is run from Limerick

Billionaire investor’s Berkshire Hathaway sinks $5.7bn into four US pharma stocks

Investors hope a gridlock in US congress would be able to stall major policy changes

Aducanumab targets clumps of protein that can build up in the brain